Potassium Hydroxide → HCID 123151441, compound
Reaction equation
[CH3:1][O:2][CH:3]=[CH:4][C:5]1[C:6]([NH2:11])=[N:7][N:8]([CH3:10])[CH:9]=1.Br[CH2:13][CH2:14][CH2:15][CH2:16][C:17](Cl)=[O:18].[OH-].[K+]>[Br-].C([N+](CCCC)(CCCC)CCCC)CCC.C1(C)C=CC=CC=1>[CH3:1][O:2][CH:3]=[CH:4][C:5]1[C:6]([N:11]2[CH2:13][CH2:14][CH2:15][CH2:16][C:17]2=[O:18])=[N:7][N:8]([CH3:10])[CH:9]=1Participants
6
Procedure
A mixture of 4-(2-methoxyvinyl)-1-methyl-1H-pyrazol-3-amine a17-1 (500 mg, 3.27 mmol, 1 eq), 5-bromovaleryl chloride (651.9 mg, 3.27 mmol, 1 eq), potassium hydroxide (550.1 mg, 9.80 mmol, 3 eq), 4-dimethymaminopyridine (39.9 mg, 0.33 mmole, 0.1 eq) and N,N,N-tributylbutan-1-aminium bromide (105.3 mg, 0.33 mmole, 0.1 eq) in toluene (15 ml) is heated to reflux overnight. After filtration and evaporation the residue is purified by reverse phase chromatography (basic mode, gradient: H2O/acetonitrile/NH4OH from 80/20/0.1 to 50/50/0.1 in 10 minutes) to afford 1-[4-(2-methoxyvinyl)-1-methyl-1H-pyrazol-3-yl]piperidin-2-one a17-2.
Workup
- temperatureis heated
- temperatureto reflux overnight
- filtrationAfter filtration and evaporation the residue
- customis purified by reverse phase chromatography (basic mode, gradient: H2O/acetonitrile/NH4OH from 80/20/0.1 to 50/50/0.1 in 10 minutes)
Sources & evidence
- ORD record
- ord-5bc34d1fd7f54b8da76c41e169fe5159
- Source dataset
- uspto-grants-2015_06
- Patent number
- US09067930B2
Reaction notes
Loading…